These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 595602)

  • 41. Long-term oral antiarrhythmic therapy with mexiletine.
    Campbell NP; Pantridge JF; Adgey AA
    Br Heart J; 1978 Jul; 40(7):796-801. PubMed ID: 687477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Experience with mexiletine in the occurrence of ventricular arrhythmias in the acute phase of myocardial infarct].
    Koller H; Prager H; Sterz H
    Adv Clin Pharmacol; 1978; 16():71-3. PubMed ID: 685751
    [No Abstract]   [Full Text] [Related]  

  • 43. Mexiletine in refractory ventricular arrhythmias.
    Fenster PE; Kern KB
    Clin Pharmacol Ther; 1983 Dec; 34(6):777-84. PubMed ID: 6641093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mexiletine for ventricular arrhythmias.
    Drug Ther Bull; 1976 Oct; 14(21):83-4. PubMed ID: 976096
    [No Abstract]   [Full Text] [Related]  

  • 45. Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.
    Chew CY; Collett J; Singh BN
    Drugs; 1979 Mar; 17(3):161-81. PubMed ID: 378646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of mexiletine in ventricular arrhythmias.
    Chaudron JM; Luwaert RJ
    Acta Cardiol; 1985; 40(6):589-98. PubMed ID: 2420104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Electrophysiological study of the mexiletine (author's transl)].
    Ebagosti A; Lodovici F; Escojido H; Torresani J; Jouve A
    Ann Cardiol Angeiol (Paris); 1979; 28(3):181-8. PubMed ID: 507723
    [No Abstract]   [Full Text] [Related]  

  • 48. [Experience with 7 year use of mexitil].
    Smolenskiĭ VS; Fomina IG; Iankin VV; Kolpakov EV; Morgunov NB
    Klin Med (Mosk); 1985 Aug; 63(8):48-52. PubMed ID: 3908809
    [No Abstract]   [Full Text] [Related]  

  • 49. [Mexitil in the treatment of ventricular arrhythmia (personal experiences)].
    Dłuzniewski M; Zalewski A; Grochowicz U; Chamiec T
    Kardiol Pol; 1983; 26(8-9):657-62. PubMed ID: 6363796
    [No Abstract]   [Full Text] [Related]  

  • 50. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
    Lotto A; Finzi A; Massari FM; Pagnoni F; Valentini R; Ambrosini F; Lo Masto M
    G Ital Cardiol; 1984 Oct; 14(10):762-7. PubMed ID: 6519385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Mexiletine in the acute treatment of ventricular arrhythmias in cardiosurgery].
    Vitale P; Agretto A; Iarussi D; Perna B; Romano A; Casale D; Porreca GP
    Minerva Cardioangiol; 1985 Dec; 33(12):815-9. PubMed ID: 2419792
    [No Abstract]   [Full Text] [Related]  

  • 52. [Treatment of ventricular arrhythmia with mexiletine (Mexitil), monitored by Holter ambulatory electrocardiography].
    Garimoldi M; Pirastu A; Barbanotti G; Sghirinzetti M; Catalano M; Castelfranco M
    Minerva Cardioangiol; 1988 Apr; 36(4):159-65. PubMed ID: 3173699
    [No Abstract]   [Full Text] [Related]  

  • 53. Electrophysiological properties of mexiletine assessed with respect to plasma concentrations.
    Joseph SP; Holt DW
    Eur J Cardiol; 1980 Feb; 11(2):115-21. PubMed ID: 7363924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Mexiletine therapy of ventricular extrasystoles in the acute phase of myocardial infarction].
    Juillard A; Bouajina A; Barrillon A; Gay J; Gerbaux A
    Ann Cardiol Angeiol (Paris); 1984; 33(2):117-20. PubMed ID: 6201121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative trial of mexiletine and lignocaine in the treatment of ventricular arrhythmias.
    Sathyamurthy I; Krishnaswami S; Padmakumar P; Mao R
    Indian Heart J; 1985; 37(6):361-5. PubMed ID: 3915491
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of oral mexiletine on left and right ventricular function.
    Stein J; Podrid P; Lown B
    Am J Cardiol; 1984 Sep; 54(6):575-8. PubMed ID: 6475776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hemodynamic and electrophysiologic effects of the new calcium antagonist Ro 11-1781 (author's transl)].
    Bödeker K; Bischoff KO; Menken U; Hager W
    Z Kardiol; 1980 Nov; 69(11):790-6. PubMed ID: 7467662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Monitoring of anti-arrhythmia drugs with the Holter system and the determination of their blood levels (mexiletine (mexitil) and amiodarone)].
    Paciaroni E; Ferroni C; Marini M; Campanari G
    Minerva Cardioangiol; 1985 May; 33(5):251-8. PubMed ID: 4033966
    [No Abstract]   [Full Text] [Related]  

  • 59. [The effect of the new antiarrhythmic drug mexiletine on sinus node and intracardiac conduction in man (author's transl)].
    Seipel L; Breithardt G; Schoerner U
    Z Kardiol; 1978 Nov; 67(11):766-70. PubMed ID: 726555
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparative study of the antiarrhythmic efficacy of mexiletine and disopyramide in patients with chronic ventricular arrhythmias.
    Breithardt G; Seipel L; Lersmacher J; Abendroth RR
    J Cardiovasc Pharmacol; 1982; 4(2):276-84. PubMed ID: 6175812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.